You are here
From on-target to off-target activity: identification and optimisation of Trypanosoma brucei GSK3 inhibitors and their characterisation as anti-Trypanosoma brucei drug discovery lead molecules.
Title | From on-target to off-target activity: identification and optimisation of Trypanosoma brucei GSK3 inhibitors and their characterisation as anti-Trypanosoma brucei drug discovery lead molecules. |
Publication Type | Journal Article |
Year of Publication | 2013 |
Authors | Woodland, A, Grimaldi, R, Luksch, T, Cleghorn, LAT, Ojo, KK, Van Voorhis, WC, Brenk, R, Frearson, JA, Gilbert, IH, Wyatt, PG |
Journal | ChemMedChem |
Volume | 8 |
Issue | 7 |
Pagination | 1127-37 |
Date Published | 2013 Jul |
ISSN | 1860-7187 |
Abstract | Human African trypanosomiasis (HAT) is a life-threatening disease with approximately 30 000-40 000 new cases each year. Trypanosoma brucei protein kinase GSK3 short (TbGSK3) is required for parasite growth and survival. Herein we report a screen of a focused kinase library against T. brucei GSK3. From this we identified a series of several highly ligand-efficient TbGSK3 inhibitors. Following the hit validation process, we optimised a series of diaminothiazoles, identifying low-nanomolar inhibitors of TbGSK3 that are potent in vitro inhibitors of T. brucei proliferation. We show that the TbGSK3 pharmacophore overlaps with that of one or more additional molecular targets. |
DOI | 10.1002/cmdc.201300072 |
Alternate Journal | ChemMedChem |
PubMed ID | 23776181 |